TSC2 c.3298G>A ;(p.V1100M)

Variant ID: 16-2129571-G-A

NM_000548.3(TSC2):c.3298G>A;(p.V1100M)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel.

Oncotarget
Gleeson, Ferga C FC; Voss, Jesse S JS; Kipp, Benjamin R BR; Kerr, Sarah E SE; Van Arnam, John S JS; Mills, John R JR; Marcou, Cherisse A CA; Schneider, Amber R AR; Tu, Zheng Jin ZJ; Henry, Michael R MR; Levy, Michael J MJ
Publication Date: 2017-11-07

Variant appearance in text: TSC2: 3298G>A; Val1100Met
PubMed Link: 29212165
Variant Present in the following documents:
  • oncotarget-08-93464-s001.pdf
View BVdb publication page



Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.

Plos One
Bodian, Dale L DL; McCutcheon, Justine N JN; Kothiyal, Prachi P; Huddleston, Kathi C KC; Iyer, Ramaswamy K RK; Vockley, Joseph G JG; Niederhuber, John E JE
Publication Date: 2014

Variant appearance in text: TSC2: V1100M
PubMed Link: 24728327
Variant Present in the following documents:
  • pone.0094554.s002.xlsx, sheet 1
View BVdb publication page